Open for inclusion

A phase Ib/II open label, multicentre study of PDR001 in combination with MCS110 in patients with advanced malignancies

Cancer type: Melanoma, Pancreatic cancer, Solide tumores

Phase: I/II

Principal Investigator: Joensuu Heikki

Country: FI

Keywords: Finland, Helsinki

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02807844?term=2016-000210-29&rank=1